Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices 49549 

Dated: August 20, 2021. 

Lauren K. Roth, 

Acting Principal Associate Commissioner for 

Policy 

[FR Doc. 2021–19096 Filed 9–2–21; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Committee on 

Blood and Tissue Safety and 

Availability 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The U.S. Department of 

Health and Human Services is hereby 

giving notice that the Advisory 

Committee on Blood and Tissue Safety 

and Availability (ACBTSA) will hold a 

virtual meeting. The meeting will be 

open to the public. The committee will 

discuss and vote on recommendations 

to improve the supply chain and data 

infrastructure that supports the blood 

industry, especially during public 

health emergencies. This meeting will 

build upon the presentations and 

discussions held during the 53rd 

ACBTSA meeting from August 17–18, 

2021. 

DATES: The meeting will take place 

virtually on Thursday, September 23, 

2021 from approximately 1:00 p.m.–4:00 

p.m. Eastern Time (ET). Meeting times 

are tentative and subject to change. The 

confirmed times and agenda items for 

the meeting will be posted on the 

ACBTSA web page at https://

www.hhs.gov/oidp/advisory-committee/ 

blood-tissue-safety-availability/ 

meetings/2021-09-23/index.html when 

this information becomes available. 

FOR FURTHER INFORMATION CONTACT: 

James Berger, Designated Federal Officer 

for the ACBTSA; Office of Infectious 

Disease and HIV/AIDS Policy, Office of 

the Assistant Secretary for Health, 

Department of Health and Human 

Services, Mary E. Switzer Building, 330 

C Street SW, Suite L600, Washington, 

DC 20024. Email: ACBTSA@hhs.gov. 

SUPPLEMENTARY INFORMATION: ACBTSA 

is a discretionary Federal advisory 

committee. ACBTSA The Committee is 

governed by the provisions of the 

Federal Advisory Committee Act 

(FACA), Public Law 92–463, as 

amended (5 U.S.C. app), which sets 

forth standards for the formation and 

use of advisory committees. On the day 

of the meeting, please go to https://

www.hhs.gov/live/index.html to view 

the meeting. The public will have an 

opportunity to present their views to the 

ACBTSA by submitting a written public 

comment. Comments should be 

pertinent to the meeting discussion. 

Persons who wish to provide written 

public comment should review 

instructions at https://www.hhs.gov/ 

oidp/advisory-committee/blood-tissuesafety-availability/meetings/2021-09-23/ 

index.html and respond by midnight 

September 16, 2021, ET. Written public 

comments will be accessible to the 

public on the ACBTSA web page prior 

to the meeting. 

ACBTSA functions to provide advice 

to the Secretary through the Assistant 

Secretary for Health on a range of policy 

issues to include: (1) Identification of 

public health issues through 

surveillance of blood and tissue safety 

issues with national survey and data 

tools; (2) identification of public health 

issues that affect availability of blood, 

blood products, and tissues; (3) broad 

public health, ethical, and legal issues 

related to the safety of blood, blood 

products, and tissues; (4) the impact of 

various economic factors (e.g., product 

cost and supply) on safety and 

availability of blood, blood products, 

and tissues; (5) risk communications 

related to blood transfusion and tissue 

transplantation; and (6) identification of 

infectious disease transmission issues 

for blood, organs, blood stem cells and 

tissues. The Committee has met 

regularly since its establishment in 

1997. 

Dated: August 27, 2021. 

James J. Berger, 

Designated Federal Officer, Advisory 

Committee on Blood and Tissue Safety and 

Availability, Office of Infectious Disease and 

HIV/AIDS Policy. 

[FR Doc. 2021–19026 Filed 9–2–21; 8:45 am] 

BILLING CODE 4150–28–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Federal Licensing of Office of Refugee 

Resettlement Facilities Request for 

Information 

AGENCY: Office of Refugee Resettlement 

(ORR), Administration for Children and 

Families (ACF), Department of Health 

and Human Services (HHS). 

ACTION: Request for information. 

SUMMARY: The Unaccompanied Children 

(UC) Program is responsible for the 

administration of childcare facilities 

throughout the country that care for 

unaccompanied children arriving in the 

United States prior to those children 

being placed with viable sponsors in the 

United States. To inform a strategic and 

impactful plan for the administration of 

these facilities HHS is issuing this 

Request for Information (RFI). The RFI 

solicits specific input regarding options 

for a Federal licensure process to ensure 

continued program operations. 

DATES: To be considered, public 

comments must be received 

electronically no later than October 4, 

2021. 

ADDRESSES: Public comments should be 

submitted online at http://

www.regulations.gov. All submissions 

must be submitted to the Docket named 

ACF–2021–0001 to ‘‘Request for 

Information (RFI) from Non-Federal 

Stakeholders: Federal Licensing of ORR 

Facilities.’’ Comments submitted 

electronically, including attachments, 

will be posted to the docket unchanged 

and available to view by the public. 

Evidence and information supporting 

your comment can be submitted as 

attachments. Please provide your 

contact information or organization 

name on the web-based form for 

possible follow up from HHS. There is 

a 5,000-character limit on comments 

and maximum number (10) of attached 

files and maximum size (10 MB) of each 

attached file. 

FOR FURTHER INFORMATION CONTACT: 

Toby Biswas, Senior Supervisory Policy 

Counsel, Division of Policy and 

Procedures, Office of Refugee 

Resettlement, Administration for 

Children and Families, Department of 

Health and Human Services, 

Washington, DC, (202) 205–4440 or 

ucpolicy@acf.hhs.gov. 

SUPPLEMENTARY INFORMATION: ORR 

facilities are currently administered 

through a nationwide network of 

grantee providers that care for 

unaccompanied children on a day-today basis. These facilities are subject to 

Federal ORR policies and regulations 

regarding their operations as well as 

applicable State-based licensure 

regulations regarding the operation of 

childcare facilities in each jurisdiction. 

The Flores Settlement Agreement 

(FSA) generally requires that ORR 

promptly place unaccompanied 

children into a State licensed child-care 

program. As of July 2021, ORR operates 

over 200 licensed care provider facilities 

in 22 states under approximately 50 

separate grants executed under 

Cooperative Agreements between ORR 

and the grantee care providers. Each 

State has its own State licensing 

standards. 

The Director of ORR and the Secretary 

of HHS have broad authority to oversee 

policies for the care of unaccompanied 

children, including by identifying a 


lotter on DSK11XQN23PROD with NOTICES1